Medicines & Treatments for COVID-19

  1. Remdesivir

Remdesivir is an antiviral given intravenously in hospitals. Since it is still a new drug, it hasn’t been approved by the FDA for use on the market. It is, however, being tested in controlled environments. Previously, the drug has shown to have an effect against Ebola, MERS, and SARS in both animal models and cells. A recent in vitro study showed that remdesivir prevented the infection of human cells from SARS-CoV-2 (the virus responsible for COVID-19). An in vitro study is done in a test tube or petri dish instead of humans or animals.

Across the US, patients with a severe case of COVID-19 are being enrolled in clinical trials for remdesivir to determine the drug’s effectiveness. Recently, results from a Phase 3 trial were announced by the manufacturer that showed that half the patients given remdesivir made improvements in ten days, whether they were treated for five days or ten days. Results also showed that by the second week, more than half the patients were discharged from the hospital.

3 of 18